Depreciation in USD of Eton Pharmaceuticals, Inc. from Q1 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Eton Pharmaceuticals, Inc. quarterly and annual Depreciation history and change rate from Q1 2018 to Q1 2025.
  • Eton Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Mar 2025 was $12,000, a 14% decline year-over-year.
  • Eton Pharmaceuticals, Inc. Depreciation for the twelve months ending 31 Mar 2025 was $48,000, a 6.7% increase year-over-year.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2024 was $50,000, a 14% increase from 2023.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2023 was $44,000, a 33% decline from 2022.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2022 was $66,000, a 57% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Eton Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $48,000 $12,000 -$2,000 -14% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $50,000 $12,000 $0 0% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q3 2024 $50,000 $12,000 +$3,000 +33% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $47,000 $12,000 +$2,000 +20% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $45,000 $14,000 +$1,000 +7.7% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $44,000 $12,000 -$1,000 -7.7% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $45,000 $9,000 -$5,000 -36% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $50,000 $10,000 -$8,000 -44% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $58,000 $13,000 -$8,000 -38% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $66,000 $13,000 -$10,000 -43% 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2025 2024 FY
Q3 2022 $76,000 $14,000 -$10,000 -42% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $86,000 $18,000 -$6,000 -25% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $92,000 $21,000 -$63,000 -75% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $155,000 $23,000 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $24,000 -$62,000 -72% 01 Jul 2021 30 Sep 2021 10-Q 16 Nov 2021 2021 Q3
Q2 2021 $24,000 -$63,000 -72% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $84,000 -$3,000 -3.4% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q3 2020 $86,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 16 Nov 2021 2021 Q3
Q2 2020 $87,000 -$2,000 -2.2% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $87,000 +$65,000 +295% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 $86,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $89,000 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $22,000 +$15,000 +214% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q1 2018 $7,000 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1

Eton Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $50,000 +$6,000 +14% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $44,000 -$22,000 -33% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $66,000 -$89,000 -57% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2025 2024 FY
2021 $155,000 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2018 $51,000 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.